Tectonic Therapeutic Statistics
Total Valuation
TECX has a market cap or net worth of $386.50 million. The enterprise value is $82.89 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TECX has 18.66 million shares outstanding. The number of shares has increased by 1,073.30% in one year.
| Current Share Class | 18.66M |
| Shares Outstanding | 18.66M |
| Shares Change (YoY) | +1,073.30% |
| Shares Change (QoQ) | +15.99% |
| Owned by Insiders (%) | 40.54% |
| Owned by Institutions (%) | 39.87% |
| Float | 9.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.92, with a Debt / Equity ratio of 0.01.
| Current Ratio | 22.92 |
| Quick Ratio | 22.67 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -659.84 |
Financial Efficiency
Return on equity (ROE) is -41.59% and return on invested capital (ROIC) is -27.43%.
| Return on Equity (ROE) | -41.59% |
| Return on Assets (ROA) | -22.89% |
| Return on Invested Capital (ROIC) | -27.43% |
| Return on Capital Employed (ROCE) | -21.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.15M |
| Employee Count | 51 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +40.31% |
| 50-Day Moving Average | 20.07 |
| 200-Day Moving Average | 30.47 |
| Relative Strength Index (RSI) | 52.25 |
| Average Volume (20 Days) | 196,232 |
Short Selling Information
The latest short interest is 1.20 million, so 6.44% of the outstanding shares have been sold short.
| Short Interest | 1.20M |
| Short Previous Month | 1.51M |
| Short % of Shares Out | 6.44% |
| Short % of Float | 12.39% |
| Short Ratio (days to cover) | 5.69 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -63.35M |
| Pretax Income | 30.68M |
| Net Income | -58.67M |
| EBITDA | -61.72M |
| EBIT | -63.35M |
| Earnings Per Share (EPS) | -$4.72 |
Full Income StatementBalance Sheet
The company has $306.25 million in cash and $2.63 million in debt, giving a net cash position of $303.61 million or $16.27 per share.
| Cash & Cash Equivalents | 306.25M |
| Total Debt | 2.63M |
| Net Cash | 303.61M |
| Net Cash Per Share | $16.27 |
| Equity (Book Value) | 301.04M |
| Book Value Per Share | 16.12 |
| Working Capital | 296.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$62.89 million and capital expenditures -$179,000, giving a free cash flow of -$63.07 million.
| Operating Cash Flow | -62.89M |
| Capital Expenditures | -179,000 |
| Free Cash Flow | -63.07M |
| FCF Per Share | -$3.38 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |